Literature DB >> 24145455

Monoallelic loss of tumor suppressor GRIM-19 promotes tumorigenesis in mice.

Sudhakar Kalakonda1, Shreeram C Nallar, Sausan Jaber, Susan K Keay, Ellen Rorke, Raghava Munivenkatappa, Daniel J Lindner, Gary M Fiskum, Dhananjaya V Kalvakolanu.   

Abstract

Gene-associated with retinoid-interferon induced mortality-19 (GRIM-19), a STAT3-inhibitory protein, was isolated as a growth-suppressive gene product using a genome-wide expression knockdown screen. We and others have shown a loss of expression and occurrence of mutations in the GRIM-19 gene in a variety of primary human cancers, indicating its potential role as tumor suppressor. To help investigate its role in tumor development in vivo, we generated a genetically modified mouse in which Grim-19 can be conditionally inactivated. Deletion of Grim-19 in the skin significantly increased the susceptibility of mice to chemical carcinogenesis, resulting in development of squamous cell carcinomas. These tumors had high Stat3 activity and an increased expression of Stat3-responsive genes. Loss of Grim-19 also caused mitochondrial electron transport dysfunction resulting from failure to assemble electron transport chain complexes and altered the expression of several cellular genes involved in glycolysis. Surprisingly, the deletion of a single copy of the Grim-19 gene was sufficient to promote carcinogenesis and formation of invasive squamous cell carcinomas. These observations highlight the critical role of GRIM-19 as a tumor suppressor.

Entities:  

Keywords:  cytokines; glucose metabolism; immune response; oxidative phosphorylation

Mesh:

Substances:

Year:  2013        PMID: 24145455      PMCID: PMC3831468          DOI: 10.1073/pnas.1303760110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  93 in total

1.  Inhibitory effect of tumor cell-derived lactic acid on human T cells.

Authors:  Karin Fischer; Petra Hoffmann; Simon Voelkl; Norbert Meidenbauer; Julia Ammer; Matthias Edinger; Eva Gottfried; Sabine Schwarz; Gregor Rothe; Sabine Hoves; Kathrin Renner; Birgit Timischl; Andreas Mackensen; Leoni Kunz-Schughart; Reinhard Andreesen; Stefan W Krause; Marina Kreutz
Journal:  Blood       Date:  2007-01-25       Impact factor: 22.113

2.  A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas.

Authors:  I Alchanati; S C Nallar; P Sun; L Gao; J Hu; A Stein; E Yakirevich; D Konforty; I Alroy; X Zhao; S P Reddy; M B Resnick; D V Kalvakolanu
Journal:  Oncogene       Date:  2006-05-29       Impact factor: 9.867

3.  Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer.

Authors:  Daniel H Barnett; Shubin Sheng; Tze Howe Charn; Abdul Waheed; William S Sly; Chin-Yo Lin; Edison T Liu; Benita S Katzenellenbogen
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

4.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

5.  Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.

Authors:  Kenneth Leslie; Cynthia Lang; Geeta Devgan; Janeen Azare; Marjan Berishaj; William Gerald; Young Bae Kim; Keren Paz; James E Darnell; Christopher Albanese; Toshiyuki Sakamaki; Richard Pestell; Jacqueline Bromberg
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

6.  Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.

Authors:  K S Chan; S Sano; K Kataoka; E Abel; S Carbajal; L Beltran; J Clifford; M Peavey; J Shen; J Digiovanni
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

7.  Tumor-suppressive activity of the cell death activator GRIM-19 on a constitutively active signal transducer and activator of transcription 3.

Authors:  Sudhakar Kalakonda; Shreeram C Nallar; Daniel J Lindner; Jiadi Hu; Sekhar P Reddy; Dhananjaya V Kalvakolanu
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

8.  Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth.

Authors:  Ling Zhang; Lifang Gao; Yang Li; Guimiao Lin; Yueting Shao; Kun Ji; Hao Yu; Jiadi Hu; Dhananjaya V Kalvakolanu; Dennis J Kopecko; Xuejian Zhao; De-Qi Xu
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531

9.  [Correlations of GRIM-19 and its target gene product STAT3 to malignancy of human colorectal carcinoma].

Authors:  Long-Bo Gong; Xue-Lai Luo; Shuang-You Liu; De-Ding Tao; Jian-Ping Gong; Jun-Bo Hu
Journal:  Ai Zheng       Date:  2007-07

10.  Beta-catenin and CD44 expression in keratoacanthoma and squamous cell carcinoma of the skin.

Authors:  Canten Tataroglu; Tuba Karabacak; Duygu Düşmez Apa
Journal:  Tumori       Date:  2007 May-Jun
View more
  18 in total

1.  Identification of Lactate-Related Gene Signature for Prediction of Progression and Immunotherapeutic Response in Skin Cutaneous Melanoma.

Authors:  Yalin Xie; Jie Zhang; Mengna Li; Yu Zhang; Qian Li; Yue Zheng; Wei Lai
Journal:  Front Oncol       Date:  2022-02-21       Impact factor: 6.244

Review 2.  GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism.

Authors:  Shreeram C Nallar; Dhan V Kalvakolanu
Journal:  Cytokine Growth Factor Rev       Date:  2016-09-15       Impact factor: 7.638

Review 3.  Interferons, signal transduction pathways, and the central nervous system.

Authors:  Shreeram C Nallar; Dhan V Kalvakolanu
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

4.  Mitochondrial GRIM-19 deficiency facilitates gastric cancer metastasis through oncogenic ROS-NRF2-HO-1 axis via a NRF2-HO-1 loop.

Authors:  Xin Wang; Tingbo Ye; Bingqian Xue; Meihua Yang; Rui Li; Xiaohui Xu; Xin Zeng; Na Tian; Liming Bao; Yi Huang
Journal:  Gastric Cancer       Date:  2020-08-08       Impact factor: 7.370

5.  [Mechanism of hepatocyte mitochondrial NDUFA13 deficiency-induced liver fibrogenesis: the role of abnormal hepatic stellate cell activation].

Authors:  X Xu; X Zeng; R Li; J Feng; D Huang; Y Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-04-20

6.  [Pathogenic role of NDUFA13 inactivation in spontaneous hepatitis in mice and the mechanism].

Authors:  Xiaohui Xu; Rui Li; Xin Zeng; Xin Wang; Bingqian Xue; Daochao Huang; Yi Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-01-30

7.  Defective i6A37 modification of mitochondrial and cytosolic tRNAs results from pathogenic mutations in TRIT1 and its substrate tRNA.

Authors:  John W Yarham; Tek N Lamichhane; Angela Pyle; Sandy Mattijssen; Enrico Baruffini; Francesco Bruni; Claudia Donnini; Alex Vassilev; Langping He; Emma L Blakely; Helen Griffin; Mauro Santibanez-Koref; Laurence A Bindoff; Ileana Ferrero; Patrick F Chinnery; Robert McFarland; Richard J Maraia; Robert W Taylor
Journal:  PLoS Genet       Date:  2014-06-05       Impact factor: 5.917

8.  High Glucose Induces Down-Regulated GRIM-19 Expression to Activate STAT3 Signaling and Promote Cell Proliferation in Cell Culture.

Authors:  Yong-Guang Li; Bei-Bei Han; Feng Li; Jian-Wu Yu; Zhi-Feng Dong; Geng-Ming Niu; Yan-Wei Qing; Jing-Bo Li; Meng Wei; Wei Zhu
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

9.  Grim19 Attenuates DSS Induced Colitis in an Animal Model.

Authors:  Jae-Kyung Kim; Seung Hoon Lee; Seon-Young Lee; Eun-Kyung Kim; Jeong-Eun Kwon; Hyeon-Beom Seo; Han Hee Lee; Bo-In Lee; Sung-Hwan Park; Mi-La Cho
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

Review 10.  Inherited Thyroid Tumors With Oncocytic Change.

Authors:  Marcelo Correia; Ana Rita Lima; Rui Batista; Valdemar Máximo; Manuel Sobrinho-Simões
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-09       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.